EQRx, Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q3 2023.
-
Location
-
Cambridge, MA
-
Fiscal year end
-
31 December
-
Latest financial report
-
06 Nov 2023
Quick Takeaways
- EQRx, Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q3 2023.
- Headline metric: Return On Equity -20%.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-7.7%</span>.
- Most recent SEC facts end date: 27 Oct 2023.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2023-10-27) highlights Return On Equity -20.3%, Return On Assets -18.7%, and Current Ratio 18.78x.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
19.8/100
Weak
Confidence medium
Return On Equity
-20%
Metric score 0.0/100
Return On Assets
-19%
Metric score 0.0/100
Financial Health
- Current Ratio
- 18.78x
- Debt to Equity
- 0.05x
Watchpoints
Return On Equity, Return On Assets, and Current Ratio
Key metrics snapshot
Return On Equity
-20%
YoY: -7.7%
Industry median:
-43%
(n=675)
View history
Return On Assets
-19%
YoY: +35%
Industry median:
-47%
(n=673)
View history
Current Ratio
18.78x
YoY: -23%
Industry median:
3.39x
(n=667)
View history
Debt-to-equity
0.05x
YoY: -50%
Industry median:
0.26x
(n=530)
View history
NetIncomeLoss YoY
-79%
YoY:
Industry median:
-0.93%
(n=641)
View history
Profitability
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Return On Equity
|
-20%
|
-7.7%
|
-43%
(n=675)
|
Q3 2023
|
Q3 2023
|
%
|
|
Return On Assets
|
-19%
|
+35%
|
-47%
(n=673)
|
Q3 2023
|
Q3 2023
|
%
|
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
18.78x
|
-23%
|
3.39x
(n=667)
|
Q3 2023
|
Q3 2023
|
x
|
|
Debt-to-equity
|
0.05x
|
-50%
|
0.26x
(n=530)
|
Q3 2023
|
Q3 2023
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
NetIncomeLoss YoY
|
-79%
|
|
-0.93%
(n=641)
|
Q3 2023
|
Q3 2023
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
487,696,181
|
-0.15%
|
Q3 2023
|
Q3 2023
|
shares
|
|
Common Stock, Shares, Outstanding
|
484,965,759
|
+1.8%
|
Q3 2023
|
Q3 2023
|
shares
|
|
Common Stock, Value, Issued
|
$49,000
|
0%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
484,229,709
|
+1.8%
|
Q3 2023
|
Q3 2023
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
484,229,709
|
+1.8%
|
Q3 2023
|
Q3 2023
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Research and Development Expense
|
$205,734,000
|
-3.5%
|
Q3 2023
|
Q3 2023
|
USD
|
|
General and Administrative Expense
|
$101,389,000
|
-26%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Operating Income (Loss)
|
$395,912,000
|
-13%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Nonoperating Income (Expense)
|
$135,597,000
|
-34%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Income Tax Expense (Benefit)
|
$0
|
|
Q3 2023
|
Q3 2023
|
USD
|
|
Earnings Per Share, Basic
|
-1
|
-80%
|
Q3 2023
|
Q3 2023
|
USD/shares
|
|
Earnings Per Share, Diluted
|
-1
|
-80%
|
Q3 2023
|
Q3 2023
|
USD/shares
|
|
Cash and Cash Equivalents, at Carrying Value
|
$315,676,000
|
-68%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Cash, Cash Equivalents, and Short-term Investments
|
$1,200,000,000
|
-20%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Assets, Current
|
$1,235,139,000
|
-19%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Other Assets, Noncurrent
|
$1,151,000
|
-87%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Assets
|
$1,240,290,000
|
-20%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Accounts Payable, Current
|
$8,103,000
|
-42%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Accrued Liabilities, Current
|
$55,623,000
|
+21%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Liabilities, Current
|
$65,786,000
|
+5%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Liabilities
|
$69,370,000
|
-52%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Accumulated Other Comprehensive Income (Loss), Net of Tax
|
$252,000
|
|
Q3 2023
|
Q3 2023
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$765,727,000
|
-52%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$1,170,920,000
|
-16%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
|
$1,170,920,000
|
-16%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Liabilities and Equity
|
$1,240,290,000
|
-20%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Common Stock, Shares Authorized
|
1,250,000,000
|
0%
|
Q3 2023
|
Q3 2023
|
shares
|
|
Common Stock, Shares, Issued
|
537,540,806
|
-0.16%
|
Q3 2023
|
Q3 2023
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0
|
0%
|
Q3 2023
|
Q3 2023
|
USD/shares
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$316,309,000
|
-68%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
|
$258,441,000
|
-75%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Operating Lease, Liability, Current
|
$2,060,000
|
-17%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Preferred Stock, Shares Issued
|
0
|
|
Q3 2023
|
Q3 2023
|
shares
|
|
Preferred Stock, Shares Authorized
|
2,000,000
|
0%
|
Q3 2023
|
Q3 2023
|
shares
|
|
Operating Lease, Payments
|
$3,900,000
|
0%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Additional Paid in Capital
|
$1,936,346,000
|
+1.5%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Preferred Stock, Shares Outstanding
|
0
|
|
Q3 2023
|
Q3 2023
|
shares
|
|
Share-based Payment Arrangement, Expense
|
$28,476,000
|
-48%
|
Q3 2023
|
Q3 2023
|
USD
|
|
Preferred Stock, Par or Stated Value Per Share
|
0
|
0%
|
Q3 2023
|
Q3 2023
|
USD/shares
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets